Abstract
Chest CT is emerging as a valuable diagnostic tool for clinical management of COVID-19 associated lung disease. Artificial intelligence (AI) has the potential to aid in rapid evaluation of CT scans for differentiation of COVID-19 findings from other clinical entities. Here we show that a series of deep learning algorithms, trained in a diverse multinational cohort of 1280 patients to localize parietal pleura/lung parenchyma followed by classification of COVID-19 pneumonia, can achieve up to 90.8% accuracy, with 84% sensitivity and 93% specificity, as evaluated in an independent test set (not included in training and validation) of 1337 patients. Normal controls included chest CTs from oncology, emergency, and pneumonia-related indications. The false positive rate in 140 patients with laboratory confirmed other (non COVID-19) pneumonias was 10%. AI-based algorithms can readily identify CT scans with COVID-19 associated pneumonia, as well as distinguish non-COVID related pneumonias with high specificity in diverse patient populations.
Original language | English (US) |
---|---|
Article number | 4080 |
Journal | Nature communications |
Volume | 11 |
Issue number | 1 |
DOIs | |
State | Published - Dec 1 2020 |
Funding
This work was supported by the NIH Center for Interventional Oncology and the Intramural Research Program of the National Institutes of Health (NIH) by intramural NIH Grants NIH Z01 1ZID # BC011242 and CL040015 and the NIH Intramural Targeted Anti-COVID-19 (ITAC) Program. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024, Task Order No. 75N91019F00129. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. NIH may have intellectual property in the field. The opinions expressed herein are those of the authors alone, and do necessarily represent those of the NIH nor the US Government. Mention of commercial products or policies should not be misconstrued as endorsement by the NIH. NIH and NVIDIA have a Cooperative Research and Development Agreement. M.B. is a recipient of the 2019 Alain Rahmouni SFR-CERF research grant provided by the French Society of Radiology together with the French Academic College of Radiology. We are thankful to Cinzia Mennini, MD, contributed toward data and discussions for this work. Thanks also for assistance in discussions and guidance: William Dahut, Tom Mistelli, John Gallin, Bruce Tromberg, Cliff Lane, Ken Rose, Jeff Solomon, Irwin Feuerstein, David Spiro, Kaiyong Sun, Rob Suh, Hayet Amalou, Corey Arnold, Dieter Enzmann, Steve Raman, Gregg Cohen, Andrew Feng, Abdul Hamid-Halabi, Kimberly Powell, Wentau Zhu, Xiaosong Wang, Jeff Plum, and Colleen Ruan.
ASJC Scopus subject areas
- General Chemistry
- General Biochemistry, Genetics and Molecular Biology
- General Physics and Astronomy